Immunic Ag
Clinical trials sponsored by Immunic Ag, explained in plain language.
-
New MS drug aims to stop relapses in their tracks
Disease control OngoingThis phase 3 study tests an oral medication called IMU-838 against a placebo in about 1,100 adults with relapsing multiple sclerosis. The goal is to see if the drug can delay or prevent relapses and reduce new brain lesions over 72 weeks. Participants must have had recent relapse…
Phase: PHASE3 • Sponsor: Immunic AG • Aim: Disease control
Last updated May 26, 2026 02:47 UTC
-
New pill aims to stop MS Flare-Ups in their tracks
Disease control OngoingThis study tests an oral medication called IMU-838 against a placebo in about 1,100 adults with relapsing multiple sclerosis (MS). The goal is to see if the drug can reduce the number of relapses (flare-ups) and limit new brain damage seen on MRI scans. Participants take the pill…
Phase: PHASE3 • Sponsor: Immunic AG • Aim: Disease control
Last updated May 18, 2026 12:11 UTC